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Abstract: Dipeptidyl peptidase III (DPP III) is a zinc-dependent peptidase that cleaves dipeptides off of N-termini of its substrates. Previous 
studies on human DPP III reveal a reaction mechanism similar to that of thermolysin. Since the active site is conserved within the DPP III family, 
it is not surprising that the mechanism determined for Bacteroides thetaiotaomicron DPP III (BtDPP III) closely resembles that of hDPP III. 
However, the hydrogen bond network within the model differs slightly from that in the human ortholog, which results in two proposed 
pathways. The calculated Gibbs activation energy of 90.1 kJ mol–1 is larger than the one calculated from kinetic data for the preferred substrate 
Arg2-2-naphthylamide at room temperature (69 kJ mol–1), suggesting the importance of treating the whole DPP III enzyme in the calculations. 
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INTRODUCTION 
IPEPTIDYL peptidases III (DPPs III) are zinc-dependent 
peptidases that cleave dipeptides off of N-termini of 
their substrates, namely peptides consisting of 3–8 amino 
acid residues.[1] According to the MEROPS database,[2] they 
belong to the M49 peptidase family which is characterized 
by five conserved regions.[3] Two of these five motifs, 
HEXXGH and E*EXR(K)AE(D) participate in the zinc ion co-
ordination. The histidines from the first motive coordinate 
the metal ion as monodentate ligands and the Glu* from 
the second motive alternately as a flexible mono- or bi-
dentate ligand. 
 As a predominantly cytosolic enzyme DPP III is 
thought to participate in the final steps of intracellular pro-
tein catabolism.[4] The mammalian enzyme participates in 
the defence against oxidative stress through activation of 
the Keap1-Nrf2 signalling pathway,[5,6] while recent studies 
on mice reveal a potential role in the blood pressure regu-
lation.[7] The physiological role of DPP III in prokaryotes is 
not yet clear, however, the studies on Caldithrix abyssi (Ca) 
and Porphyromonas gingivalis (Pg) revealed the products 
of DPP III hydrolysis as an important source of nutrition for 
these microorganisms,[8–10] stressing the importance of 
peptidases in their metabolic pathways. Further on, PgDPP 
IV has been reported to effect the connective tissue degra-
dation, thus increasing the Pg pathogenicity. 
 Bacteroides thetaiotaomicron (Bt) is a Gram-nega-
tive anaerobe and a predominant member of the intestinal 
microbiota in mammals,[11,12] where it plays an important 
role in lactose[13] and certain glycans' degradation.[14] Alt-
hough B. thetaoitaomicron increases both innate and ac-
quired immunity,[15,16] it is also an opportunistic pathogen, 
resistant to the wide range of antibiotics.[17,18] In view of the 
new findings on the role of DPP III in the defence against 
oxidative stress in mammals, the potential effect on 
aerotolerance in anaerobic opportunistic pathogens such as 
B. thetaiotaomicron is of interest for clinical investigations.[19]  
 Crystal structures of BtDPP III (PDB codes: 5NA7 and 
5NA8) reveal a two-domain protein whose domains are 
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subject to the long-range conformational changes, from the 
so-called "open" to the "closed" form.[20,21] This is in line 
with previously reported results for the human ortholog,[22] 
where the closed enzyme form has been identified as the 
catalytically active.[23,24] The zinc-binding site is located in 
the upper domain, along with the DPP III trademark 
motives HECLGH and EEARAD. Long MD simulations of DPP 
III orthologs with various substrates revealed that the 
lowest-energy binding mode is the one with the substrate 
bound in the vicinity of the conserved 383GINL β-sheet 
(Figure 1).[21,25,26]  
 A mechanism of the peptide bond hydrolysis in the 
human ortholog has recently been proposed.[27] It is based 
on the similarity of the DPP III active site with that of the 
enzyme thermolysin,[28] whose catalytic mechanism had 
been studied earlier.[29] According to Tomić et al., the 
reaction rate is controlled by the first two steps, the 
glutamate-assisted water nucleophilic attack and the 
subsequent nitrogen inversion.[27] However, due to the lack 
of any crystal structure of BtDPP III – substrate complexes 
and the significantly different substrate affinity between 
hDPP III and BtDPP III (for example kcat values for the 
preferred synthetic substrate Arg2-2-naphthylamide are 
21.8 and 5.0 s–1, respectively),[30,31] we felt prompted to 
investigate the BtDPP III reaction mechanism. 
 
EXPERIMENTAL 
The BtDPP III active site model was prepared manually 
based on the open BtDPP III crystal structure (PDB code: 
5NA7),[20] the crystal structure of the hDPP III complex with 
leu-enkephalin (PDB code: 5E3A)[32] used in previous 
QM/MM studies[27] and the complex with Arg2-2-naphthyl-
amide (RRNA) obtained from long MD simulations.[21] The 
model consists of the zinc ion, necessary for the catalytic 
activity,[33] His448, His453 and Glu476 which coordinate the 
zinc ion,[3,34] a water molecule required for the peptide 
bond hydrolysis, Glu449 which activates the water mole-
cule according to the mechanism proposed for the human 
ortholog,[27] His533 and Tyr309 taking part in the substrate 
stabilization[21,27] and a model substrate CH3CO-Gly-NHCH3 
(Figure 2). His448 and His453 were kept neutral, with their 
Nδ sites protonated, whereas His533 was in protonated 
state since QM/MM studies on the human ortholog show 
that the reaction is not feasible with neutral His568 analo-
gous to His533 in BtDPP III.[27] All the residues were capped 
by replacing the Cβ atom with a methyl group whose coor-
dinates were restrained. The system was described using 
the B97D functional[35] in conjunction with the 6-31G(d) ba-
sis set for C, H, N and O atoms, whereas the zinc ion was 
described using the LANL2DZ-ECP basis set36 since the pre-
vious works on the human ortholog were performed at the 
same level of theory.[27] B97D was chosen since it accounts 
for dispersion and has been successfully used to describe 
zinc-dependent metalloenzymes previously.[37] Further on, 
as a non-hybrid functional, it offers a good compromise be-
tween accuracy and computing time. The solvent was 
treated implicitly, using the PCM model with SMD correc-
tions[38] and a default dielectric constant of water (78.39). 
All calculations were performed using the Gaussian 09 pro-
gram package.[39]  
 
RESULTS AND DISCUSSION 
In the optimized structure of the enzyme-substrate 
complex model (ES), the zinc ion is coordinated by His448, 
His453, Glu476 and one water molecule (Figure 2), bringing 
its coordination to 4, which is in line with previous results 
of QM/MM calculations on the human DPP III.27 The 
carbonyl group from the scissile peptide bond of the model 
substrate, namely the Os atom, is in the vicinity of the Zn2+ 
ion, but not within its coordination sphere (3.24 Å). The 
water molecule, required for the peptide bond hydrolysis, 
is strongly polarized by the carboxyl group of Glu449, which 
is reflected in the Ow–Hw and Hw–Oe distances (Table S1). 
Evolutionally conserved His533 and Tyr309 stabilize the 
substrate; His533 through the hydrogen bond between Nε 
 
 
Figure 1. Arg2-2-naphthylamide (RRNA) binding mode 
identified by long MD simulations.[21] The conserved 383GINL 
β-sheet is shown in red, RRNA atoms as blue sticks and Zn2+ 
as a grey sphere. The figure was prepared using the PyMOL 
program.[43]  
 
 
 
Figure 2. Minimal model of the BtDPP III active site with the 
model substrate. His533 and Tyr309 have been omitted for 
clarity. 
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and Os, while the hydroxyl group of Tyr309 interacts with 
the substrate backbone. 
Nucleophilic Water Addition 
Like in the case of human ortholog, the first reaction step 
involves Glu449-assisted nucleophilic addition of the hy-
droxyl group to the scissile peptide bond carbonyl group 
(Figure 3). The subsequent change in the Cs hybridization 
results in Os entering the Zn2+ ion coordination sphere, 
while the Ow–Zn distance increases (Table S1). The role of 
the conserved His533 is twofold; its Nε atom forms a hydro-
gen bond with the carbonyl oxygen Os which both de-
creases the density of the negative charge within the 
carbonyl group and positions it in a way that allows for a 
nucleophilic attack to occur (Os–Cs–Ow angle is 83.7° in the 
identified enzyme-substrate complex). This reaction step 
has the highest Gibbs activation energy of 90.1 kJ mol–1. 
The role of the zinc ion in stabilizing the oxyanion is re-
flected in the rapid drop of the Os-Zn distance in the TS1 
transition state. Os entrance in the Zn2+ coordination 
sphere is accompanied by a significant distortion of the 
planar structure present in the ES complex, as noted by 
changes in the Ow-Cs distance and ω1 and ω2 values, ulti-
mately resulting in a tetrahedral geometry present in 
INT1. 
Nitrogen Inversion 
The configuration of the Ns atom in the INT1 intermediate 
does not allow for a proton transfer from the Glu449 due 
to steric reasons (Figure 3). The inversion of the Ns atom 
 
 
Figure 3. Reaction mechanism of the Glu449-assisted water addition and nitrogen inversion. Reaction intermediates are 
denoted as INTn and transition states as TSn. Hydrogen bonds are shown as dashed lines, while the bonds in the process of 
formation or cleavage are represented by dotted lines. His533 and Tyr309 have been omitted for clarity. 
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configuration (nitrogen inversion) is required in order to 
orient the Ns lone pair towards the protonated Glu449 (Fig-
ure 3). Such a transformation is usually a rapid process, 
with the inversion energy of trimethylamine (at 300 K) 
being about 34.7 kJ mol–1.[40] The inversion occurs through 
a nearly planar transition state (ω1 in TS2 is 171.9°), with 
the activation barrier of 21.1 kJ mol–1. The structures INT1 
and INT2 differ solely in the Ns atom configuration. 
According to the energy profile (Figure 4), the R isomer 
(INT1) is 3.7 kJ mol–1 more stable than the S isomer (INT2), 
while the energy barrier for INT2 to INT1 reversal is  
17.4 kJ mol–1. In case of the human DPP III a translocation 
of the Glu451 (Glu449 in BtDPP III), accompanied by 
formation of two hydrogen bonds, was proposed as a way 
of inhibiting the reversal of INT2 to INT1.[27] Although we 
were not able to identify the transition state for this 
transformation within the model system used, the same 
behaviour was assumed. However, unlike the human 
ortholog, the hydrogen bond between Hw2 and the carbonyl 
oxygen atom was preserved in INT3 (Figure 3, Table S1). As 
a result, two possible Ns protonation pathways were 
considered: one where the Cs-Ow bond rotation and 
formation of the Hw2-Oe2 hydrogen bond precede the 
proton transfer from Glu449 to Ns and the other where 
protonation occurs before the Hw2–Oe2 hydrogen bond 
formation (Figure 5). According to our calculations, the 
proton transfer from Glu449 to Ns followed by the Cs–Ow 
bond rotation result in a lower energy pathway than the 
alternative (Figures 4 and 5) due to the lower energies of 
the TS4b and TS5b transition states. When Gibbs energies 
at room temperature are compared, which include the 
zero-point energy and the thermal effects of vibration, the 
transition from INT3 to INT4b became barrierless. Also, ex-
cept for TS1, energies of all transition states and intermedi-
ates significantly decrease. 
 
 
Figure 5. Two possible pathways from INT3 to INT5. Reaction intermediates are denoted as INTn and transition states as TSn. 
Hydrogen bonds are shown as dashed lines, while the bonds in the process of formation or cleavage are represented by dotted 
lines. His533 and Tyr309 have been omitted for clarity. 
 
Figure 4. Energy profile for the amide bond hydrolysis in the 
BtDPP III active site model calculated at the B97D/[6-31G(d) 
+ LANL2DZ-ECP] level of theory. Electronic energies are 
shown as grey squares; estimated Gibbs energies at room 
temperature shown as black squares. 
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 It should be noted that Ns−Cs has a partial double 
bond character (d(Cs−Ns)=1.34 Å) in the ES complex while in 
the intermediates INT1-INT3 and INT4a it has the single 
bond character. The proton transfer from Glu449 to Ns 
significantly affects this bond, resulting in its elongation by 
0.1 Å. All intermediates and transition states are stabilized 
by a hydrogen bond with the Nε-bound proton of His533, 
while Tyr309 stabilizes the substrate to a minor degree. 
Amide Bond Cleavage 
Unlike for the human ortholog where the proton transfer 
and the amide bond cleavage occur concertedly,[27] in the 
case of BtDPP III the intermediate containing the proto-
nated amino- group (INT5) was identified (Figure 6). The 
conformation of INT5 satisfies the stereoelectronic criteria 
according to Deslongchamps, i.e. the Os and Ow atoms 
(bound to Cs) both have lone-pair orbitals antiperiplanar to 
the scissile Cs–Ns bond.[41] The subsequently formed me-
thylamine is stabilized through the hydrogen bond with the 
carboxyl group of Glu449. The next steps in product for-
mation would be the proton transfer from Ow to the newly 
formed amine, as suggested in case of thermolysin.[42] In 
the case of hDPP III this resulted with Ow entering the Zn2+ 
coordination sphere (wherein Os moves out of the zinc co-
ordination sphere) and establishing the initial coordination 
of the metal ion.[27] However, these reaction steps are not 
crucial for understanding the peptide bond cleavage and as 
such are not discussed in this paper. 
 Differently from the reaction determined for the 
human DPP III, where the rate is determined by the first and 
the second reaction step, in the case of BtDPP III the 
peptide hydrolysis is determined by the first step solely, the 
Glu449-assisted water addition. The respective Gibbs 
activation energy (90.1 kJ mol–1) is higher than the 
activation energy derived from the experimental data 
reported by Vukelić et al. for the preferred synthetic 
substrate Arg2-2-naphthylamide, kcat of 5.0 s–1.[30] Despite 
 
Figure 6. Reaction mechanism of the Cs-Ns bond cleavage. Hydrogen bonds are shown as dashed lines, while the bonds in the 
process of formation or cleavage. 
 
Table 1. Relative Gibbs energies for the intermediates and 
transition states proposed for the BtDPP III catalysed 
peptide bond hydrolysis at room temperature. 
 ΔGrel / kcal mol–1 
ES 0.0 
TS1 90.10 
INT1 66.68 
TS2 87.78 
INT2 70.35 
INT3 77.18 
TS4a 81.31 
TS4b 76.02 
INT4a 76.45 
INT4b 56.36 
TS5a 78.99 
TS5b 68.08 
INT5 56.33 
TS6 68.39 
P 8.012 
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the different substrates, in the model system and the 
experiment, the obtained energy prompts additional 
computational studies of the BtDPP III substrate binding. 
 
CONCLUSION 
The mechanism of the peptide bond hydrolysis catalysed by 
the DPP III from Bacteroides thetaiotaomicron was 
investigated using QM calculations on a model system 
constructed from the available BtDPP III crystal structure 
and molecular docking results. The main steps in the 
peptide bond hydrolysis are the Glu449-assisted water 
addition, the inversion of the configuration on the amide 
nitrogen atom, its protonation and C−N bond cleavage. 
 According to our calculations the rate-determining 
step of the peptide hydrolysis reaction catalysed by BtDPP 
III is the Glu449-assisted water addition. The translocation 
of Glu449 and subsequent locking of the nitrogen atom 
configuration immediately after its inversion, proposed in 
case of the human ortholog, was not observed in the BtDPP 
III catalysed reaction. The preferred pathway seems to be 
the one where the amide nitrogen protonation occurs first, 
with the second substrate-Glu449 hydrogen bond forming 
in a separate step. Further on, the protonation of the amide 
nitrogen and the C-N bond cleavage are not concerted like 
in case of human DPP III. 
 The difference between the calculated Gibbs 
activation energy of the rate-determining step and the 
available experimental data underline the difficulty of 
creating a simple model of such a plastic active site. Our 
results stress the need for inclusion of the entire protein in 
further calculations and are in line with the significant 
difference in results obtained by QM and QM/MM 
approaches in previous studies on the human ortholog. 
 
REFERENCES 
[1] M. Chen, A. J. Barrett, Handbook of Proteolytic 
Enzymes, 2. ed., Elsevier, London, 2004, 809–812. 
[2] N. D. Rawlings, A. J. Barrett, R. Finn, Nucleic acids 
research 2015, 44, D343. 
[3] M. Abramić, J. Špoljarić, Š. Šimaga, Period Biol. 2004, 
106, 161. 
[4] M. Abramić, M. Zubanović, L. Vitale, Biol. Chem. 
Hoppe-Seyler 1988, 369, 29. 
[5] Y. Liu, J. T. Kern, J. R. Walker, J. A. Johnson, P. G. 
Schultz, H. Luesch, Proc Natl Acad Sci U S A 2007, 
104, 5205. 
[6] B. E. Hast, D. Goldfarb, K. M. Mulvaney, M. A. Hast, 
P. F. Siesser, F. Yan, D. N. Hayes, M. B. Major, Cancer 
Res. 2013, 73, 2199. 
[7] X. Pang, A. Shimizu, S. Kurita, D.P. Zankov, K. 
Takeuchi, M. Yasuda-Yamahara, S. Kume, T. Ishida, 
H. Ogita, Hypertension 2016, 68, 630. 
[8] I. V. Kublanov, O. M. Sigalova, S. N. Gavrilov, A. V. 
Lebedinsky, C. Rinke, O. Kovaleva, N. A. Chernyh, N. 
Ivanova, C. Daum, T. B. Reddy et al., Front Microbiol. 
2017, 8, 195. 
[9] T. K. Nemoto, Y. Ohara-Nemoto, Japanese Dental 
Science Review 2016, 52, 22. 
[10] T. K. Nemoto, Y. Ohara-Nemoto, G. A. Bezerra, Y. 
Shimoyama, S. Kimura, J. Biol. Chem. 2016, 291, 
5913. 
[11] L. E. Comstock, M. J. Coyne, Bioessays 2003, 25, 926. 
[12] J. Xu, M. K. Bjursell, J. Himrod, S. Deng, L. K. 
Carmichael, H. C. Chiang, L. V. Hooper, J. I. Gordon, 
Science 2003, 299, 2074. 
[13] G. A. O'Toole, J Bacteriol. 2016, 198, 2763. 
[14] D. Ndeh, A. Rogowski, A. Cartmell, A. S. Luis, A. Basle, 
J. Gray, I. Venditto, J. Briggs, X. Zhang, A. Labourel et 
al., Nature 2017, 544, 65. 
[15] M. A. Zocco, M. E. Ainora, G. Gasbarrini, A. Gasbarrini, 
Digestive and Liver Disease 2007, 39, 707. 
[16] L. V. Hooper, J. Xu, P. G. Falk, T. Midtvedt, J. I. 
Gordon, Proc. Natl. Acad. Sci. 1999, 96, 9833. 
[17] I. Brook, Expert Rev. Anti Infect Ther. 2007, 5, 991. 
[18] E. Nagy, E. Urbán, Clinical Microbiology and Infection 
2011, 17, 371. 
[19] P. Y. Tang, M. M. Dallas, M. H. Malamy, Mol 
Microbiol. 1999, 32, 139. 
[20] I. Sabljić, N. Meštrović, B. Vukelić, P. Macheroux, K. 
Gruber, M. Luić, M. Abramić, PLOS ONE 2017, 12, 
e0187295. 
[21] M. Tomin, S. Tomić, Molecular BioSystems 2017, 13, 
2407. 
[22] G. A. Bezerra, E. Dobrovetsky, R. Viertlmayr, A. Dong, 
A. Binter, M. Abramić, P. Macheroux, S. Dhe-
Paganon, K. Gruber, Proc Natl Acad Sci U S A 2012, 
109, 6525. 
[23] A. Tomić, M. Gonzalez, S. Tomić, J Chem Inf Model 
2012, 52, 1583. 
[24] A. Tomić, S. Tomić, Dalton Trans 2014, 43, 15503. 
[25] I. Sabljić, M. Tomin, M. Matovina, I. Sučec, A. 
Tomašić Paić, A. Tomić, M. Abramić, S. Tomić, PloS 
One 2018, 13, e0192488. 
[26] A. Tomić, M. Berynskyy, R. C. Wade, S. Tomić, Mol. 
Biosyst. 2015, 11, 3068. 
[27] A. Tomić, B. Kovačević, S. Tomić, Phys. Chem. Chem. 
Phys. 2016, 18, 27245. 
[28] P. K. Baral, N. Jajčanin-Jozić, S. Deller, P. Macheroux, 
M. Abramić, K. Gruber, J. Biol. Chem. 2008, 283, 
22316. 
[29] J. Blumberger, G. Lamoureux, M. Klein, J. Chem. 
Theory Comput. 2007, 3, 1837. 
[30] B. Vukelić, B. Salopek-Sondi, J. Špoljarić, I. Sabljić, N. 
Meštrović, D. Agić, M. Abramić, Biol. Chem. 2012, 
393, 37. 
 
 
 
 M. TOMIN et al.: The Mechanism of Peptide Hydrolysis … 193 
 
DOI: 10.5562/cca3343 Croat. Chem. Acta 2018, 91(2), 187–193 
 
 
 
[31] J. Špoljarić, B. Salopek-Sondi, J. Makarević, B. 
Vukelić, D. Agić, Š. Šimaga, N. Jajčanin-Jozić, M. 
Abramić, Bioorg. Chem. 2009, 37, 70. 
[32] P. Kumar, V. Reithofer, M. Reisinger, S. Wallner, T. 
Pavkov-Keller, P. Macheroux, K. Gruber, Sci. Rep. 
2016, 6, 23787. 
[33] K. Fukasawa, K. M. Fukasawa, M. Kanai, S. Fujii, J. 
Hirose, M. Harada, Biochem. J. 1998, 329, 275. 
[34] K. Fukasawa, K. M. Fukasawa, H. Iwamoto, J. Hirose, 
M. Harada, Biochemistry 1999, 38, 8299. 
[35] S. Grimme, J. Comput. Chem. 2006, 27, 1787. 
[36] P. J. Hay, W. R. Wadt, J. Chem. Phys. 1985, 82, 299. 
[37] N. Gresh, K. El Hage, D. Perahia, J. P. Piquemal, C. 
Berthomieu, D. Berthomieu, J. Comput. Chem. 2014, 
35, 2096. 
[38] A. V. Marenich, C. J. Cramer, D. G. Truhlar, J. Phys. 
Chem. B 2009, 113, 6378. 
[39] Gaussian 09 (Versions A. 01 and D. 01), M. Frisch, G. 
Trucks, H. Schlegel, G. Scuseria, M. Robb, J. 
Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. 
Petersson, Gaussian, Inc., Wallingford CT, 2009. 
[40] A. M. Halpern, M. J. Ondrechen, L. D. Ziegler, J. Am. 
Chem. Soc. 1986, 108, 3907. 
[41] P. Deslongchamps, Tetrahedron 1975, 31, 2463. 
[42] V. Pelmenschikov, M. Blomberg, P. Siegbahn, J. Biol. 
Inorg. Chem. 2002, 7, 284. 
[43] The PyMOL Molecular Graphics System, Version 1.8 
Schrödinger, LLC, 2017. 
 
